Stock listing

Oncosil Medical Ltd

Selected listing: OSL · ASX · AUD · AU

Oncosil Medical Ltd (ASX:OSL), Health Technology. Latest release Sep 8, 2026: Australian Manufacturing Facility Achieves ISO 13485.

OSL:ASXAUDAUUpdated October 2, 2026
Oncosil Medical Ltd logo
Ticker
ASX:OSL
Asset type
Stock
Sector
Health Technology
Industry
Medical Specialties
Exchange
ASX
Currency
AUD

About Oncosil Medical Ltd

Oncosil Medical Ltd is a public company listed on the Australian market under the ticker OSL. Oncosil focuses on developing innovative medical technologies for the treatment of cancer.

Latest news from Oncosil Medical Ltd

Australian Manufacturing Facility Achieves ISO 13485

September 8, 2026

OSL Secures $5.6 million from Major Institutional Investors

September 7, 2026

OncoSil Receives FDA Approval for Distal Cholangiocarcinoma

August 16, 2026

OncoSil Medical Completes Manufacturing Validation

July 12, 2026

OncoSil Medical Files for FDA Approval

July 2, 2026

All Oncosil Medical Ltd news →

Research Oncosil Medical Ltd

Oncosil Medical Ltd company profile

View the public company page for Oncosil Medical Ltd on 6ix.

Oncosil Medical Ltd news

Read company news and market updates connected to Oncosil Medical Ltd.

Oncosil Medical Ltd investor events

Find investor webinars, events, and replay context for Oncosil Medical Ltd.

Alternate listings

OCMLF:OTC

US · USD

Alternate listing for Oncosil Medical Ltd; the primary context on this page is OSL:ASX.